Sign in

CIK 0001724521

  • Large accelerated filer

Arcus Biosciences, Inc.

Sign in to watch
Ticker
RCUS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
473898435
Phone
+1 510-694-6200
Business address
3928 POINT EDEN WAY, HAYWARD, CA, 94545
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$84,810
in 1 filing, $85K under 10b5-1 plans

Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Azoy Alexander −$85K Chief Accounting Officer sold 7% of stake

Reading 59 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-01-23 Markus Richard Chief Medical Officer Grant or award +24,000 89,647
2026-01-23 Markus Richard Chief Medical Officer Grant or award · Stock Option (right to buy) +96,000 96,000
2025-12-17 Markus Richard Chief Medical Officer Sale 10b5-1 −4,494 $22.16 $100K 65,647
2025-12-16 Markus Richard Chief Medical Officer Sale 10b5-1 −5,052 $21.88 $111K 70,141
2025-02-10 Markus Richard Chief Medical Officer Grant or award +75,193 75,193
2025-02-10 Markus Richard Chief Medical Officer Grant or award · Stock Option (right to buy) +305,328 305,328

Page 1 of 1 · 6 trades